SPL 2.11% 9.3¢ starpharma holdings limited

Ann: AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor, page-80

  1. 12,863 Posts.
    lightbulb Created with Sketch. 1411
    My apologies. Misinterpreted your post Sarge
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.